Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Camphene is a bicyclic monoterpene found as a minor constituent in many essential oils, including turpentine, cypress oil, and citronella oil. It is used primarily as a flavoring agent and fragrance additive in food and cosmetic products[1][3]. Camphene has demonstrated hypolipidemic effects by lowering cholesterol and triglyceride levels in animal models of hyperlipidemia; its mechanism appears to be independent of HMG-CoA reductase inhibition (unlike statins), instead involving upregulation of SREBP-1 expression and likely inhibition of microsomal triglyceride transfer protein (MTP)[2][4]. Additionally, camphene exhibits antioxidant, anti-inflammatory, analgesic, and cardioprotective properties through modulation of oxidative stress pathways[5][6]. It is not an approved pharmaceutical drug but has been studied for potential therapeutic roles in cardiovascular disease prevention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Camphene.